COPD patients will get access to Dupixent via NHS Almost 30,000 people in England with COPD stand to get access to Dupixent, the first biologic for the devastating disease, after NICE backs its use.

#COPDpatients #Dupixent #dupilumab #NHS #chronicobstructivepulmonarydisease #COPD #biologics #Sanofi #Regeneron #uncontrolledCOPD #lungdisease #COPDtherapies #NICEfinaldraftguidance #COPDflareups #COPDdiagnosis #NICE #NHScostsavings #uncontrolledCOPD #COPDcare
zurl.co/7i5io

MHRA approves Nucala for eosinophilic COPD in adults on triple therapy - PharmaTimes New biologic option shown to reduce exacerbations and extend time to first flare

#MHRA #GSK #Nucala #mepolizumab #eosinophilicCOPD #tripletherapy #biologics #UK #addonmaintenancetreatment #uncontrolledCOPD #MATINEE #METREX #KingsCentreforLungHealth #RespiratoryMedicine #COPDpatients #NICE #emergencyhospitaladmissions #COPDExacerbations #SMC #reimbursement
zurl.co/ro5Og